Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001092911 | SCV001249648 | pathogenic | not provided | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003588719 | SCV004294919 | likely pathogenic | Carnitine palmitoyl transferase 1A deficiency | 2023-06-12 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CPT1A protein function. ClinVar contains an entry for this variant (Variation ID: 872449). This missense change has been observed in individual(s) with carnitine palmitoyltransferase 1A deficiency (PMID: 23430868). This variant is present in population databases (no rsID available, gnomAD 0.003%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 56 of the CPT1A protein (p.Pro56Leu). |